Cargando…
Can the fNIRS-derived neural biomarker better discriminate mild cognitive impairment than a neuropsychological screening test?
INTRODUCTION: Early detection of mild cognitive impairment (MCI), a pre-clinical stage of Alzheimer’s disease (AD), has been highlighted as it could be beneficial to prevent progression to AD. Although prior studies on MCI screening have been conducted, the optimized detection way remain unclear yet...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126359/ https://www.ncbi.nlm.nih.gov/pubmed/37113573 http://dx.doi.org/10.3389/fnagi.2023.1137283 |